Department of Respiratory Medicine, Yancheng Third People's Hospital, the Affiliated Yancheng Hospital of Southeast University Medical College, Yancheng, Jiangsu 224001, China.
Department of Oncology, Suzhou Hospital of Anhui Medical University (Suzhou Municipal Hospital of Anhui Province), Suzhou, Anhui 234000, China.
Discov Med. 2021 Mar-Apr;31(163):57-60.
Remdesivir is a broad-spectrum antiviral agent. With the rapid spread of Coronavirus disease 2019 (COVID-19) globally, remdesivir is taking the spotlight for COVID-19 treatment. Despite the promising signs of anti-CoV activity in several preclinical and clinical studies, more data of remdesivir in the treatment of COVID-19 is still needed for evaluating its efficacy.
瑞德西韦是一种广谱抗病毒药物。随着 2019 年冠状病毒病（COVID-19）在全球的迅速传播，瑞德西韦成为 COVID-19 治疗的焦点。尽管在几项临床前和临床研究中瑞德西韦具有抗 CoV 活性的迹象，但仍需要更多关于瑞德西韦治疗 COVID-19 的数据来评估其疗效。
